The Cancer Institute offers annual internal funding opportunities specifically for cancer research projects. UAMS additionally offers a variety of internal funding opportunities that are available, but not restricted to, cancer researchers. External funding opportunities of note to cancer researchers may also be highlighted in this section.

UAMS Vice-chancellor for Research Grant Opportunities

Two new campus-wide grant programs are sponsored through the Office of the Vice-Chancellor for Research.

  • The DEAP grant program, which provides funds to help investigators address reviewer comments on scored, but unfunded grant
  • 2.  The Faculty Research Enhancement (FRE) award, which is a new program to provide short-tern support to enhance research capabilities

Read more about these programs at:

Center for Musculoskeletal Disease Research (CMDR) Request for Pilot Project Applications

RFP Released August 21, 2018

Application Deadline October 21, 2018

The Center for Musculoskeletal Disease Research is a Center of Biomedical Research Excellence (COBRE) at UAMS funded by the National Institute of General Medical Sciences (NIGMS). The CMDR is a multidisciplinary center that encompasses a broad area of musculoskeletal research, including osteoporosis, orthopedics, biomechanics, multiple myeloma, cancer metastases to bone, osteoarthritis, osteomyelitis, and aberrant skeletal development. The long-range goal of the Center is to establish the scientific foundation for sustained excellence in musculoskeletal research in central Arkansas. One important component of this effort is to fund pilot projects as a means of supporting the efforts of musculoskeletal investigators to pursue extramural funding. More information on how the CMDR is structured, our core facilities, and services can be obtained by visiting our website ( or by contacting the CMDR Director, Dr. Charles O’Brien at

The Pilot Project Research Program will provide up to $65,000 direct costs for one year’s support of research projects aligned with the CMDR focus. Two awards will be made annually.  Funded pilot investigators will have access to all of the CMDR’s core laboratories and facilities.  Successful applications will be relevant to the focus of the CMDR, collaborative, and likely to lead to extramural funding. Funded pilot investigators will be required to participate in local and national COBRE and IDeA (Institutional Development Award) meetings, to give periodic progress reports when requested, and to submit a comprehensive final written report. Salary support is allowed for laboratory personnel but not for the Principal Investigator.

The application must be focused on musculoskeletal research.  Applicants are strongly encouraged to contact Dr. O’Brien prior to submitting an application. The ideal applicant is a new, early stage investigator, with a tenure-track faculty position and strong evidence of institutional support (designation of lab space, start-up funds, etc.).  Only current UAMS-affiliated faculty members are eligible.

Department of Health and Human Services Invites Applications for Modular R01s in Cancer Control and Population Sciences

RFP Released July 24, 2018

Application Deadlines Vary but Include November 7, 2018 and March 6, 2019

This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science. Learn More

Center for Microbial Pathogenesis and Host Inflammatory Responses, College of Medicine – UAMS

RFP Released September 11, 2018

Application Deadline November 30, 2018

The Center for Microbial Pathogenesis and Host Inflammatory Responses is a Center of Biomedical Research Excellence (COBRE) funded by the National Institute of General Medical Sciences (NIGMS). Its goal is to facilitate infectious disease research at UAMS and its affiliated campuses. The overall theme is to define interactions between diverse microbial pathogens and their common human host as a necessary prelude to the development of novel diagnostic and therapeutic modalities that can be used to manipulate these interactions in favor of the host. One important component of this effort is to fund pilot projects as a means of encouraging other investigators to expand their research efforts in a manner consistent with the underlying theme of the Center. Preference will be given to junior investigators who have not previously received R01-level funding, but more senior investigators may be considered if the proposal represents a clear expansion of their work in a manner consistent with the underlying theme of the Center. Applicants are encouraged to address any questions about suitability to the Center Director, Dr. Mark S. Smeltzer, before submitting a proposal (  Administrative questions should be directed to Rhonda Anthony (  Project awards can be up to $50,000 per year with a start date of May 1, 2019. Salary support is allowed for laboratory personnel but not for the Principal Investigator.  Carry forward is not allowed, but a second year of support is possible given satisfactory progress.

Only current UAMS-affiliated faculty members are eligible. Review criteria will focus on quality of the science, consistency with the underlying theme of the Center, and the potential to enhance the broader research enterprise around this theme. Preference will be accorded to projects involving collaboration with Center-funded investigators. Applications will be forwarded to members of the External Advisory Committee (EAC) for their review. The principal investigator of applications judged to be competitive will be asked to present their application to members of the EAC at the on-site meeting to be held January 8-9, 2019. Assuming adequate funds, applications deemed worthy of funding will then be forwarded to NIGMS program staff for final approval.  Applications must be submitted via e-mail to Rhonda Anthony ( using NIH PHS398 forms ).

Damon Runyon Cancer Research Foundation Invites Applications for Physician-Scientist Training Award

RFP Released April 3, 2018
Application Deadline is December 3, 2018

The annual program provides physicians who wish to pursue a career in cancer research with the opportunity for a protected research training experience under the mentorship of a highly qualified mentor after they have completed their clinical training. The Damon Runyon Cancer Research Foundation is accepting applications to its new Physician-Scientist Training Award program.

The goals of the program are to transform these individuals into physician-scientists capable of conducting research that has the potential to transform the diagnosis, treatment, and/or prevention of cancer; and to eliminate the financial disincentive to embarking on such a career path.

The award program will provide up to $460,000 over four years in financial support. In addition, the foundation will retire up to $100,000 of any outstanding medical school debt owed by a grant recipient.

To be eligible, physician-scientist applicants (MDs only) must have completed their residencies and clinical training, be U.S. Specialty Board eligible prior to the award start date and be able to devote at least 80 percent of their time and effort to Damon Runyon-supported research.

College of Medicine Intramural Grant Program

Awards are made only to full-time faculty members (including VA appointments) of the College of Medicine who are at the rank of instructor or above. Fellows, postdocs, and individuals in temporary positions are not eligible. Individuals at the level of instructor require a letter from the department Chairperson confirming that the individual is not in a temporary position and that the department intends to develop the individual as a faculty member. Recipients may hold only one College of Medicine Intramural Grant at a time. Individual programs have additional eligibility requirements that are described below. Eligible faculty members may submit only one application per deadline on which they are Principal Investigator.  Learn More

AACR NextGen Grants for Transformative Cancer Research

RFP Released August 22, 2018

Application Deadline January 18, 2019

The AACR NextGen Grants for Transformative Cancer Research represent the AACR’s flagship funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence.

The grants provide $450,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, graduate students (including tuition costs), and research assistants, research/laboratory supplies, equipment, travel applicable to the research project, publication charges for manuscripts that pertain directly to the funded project, other research expenses, and indirect costs.   Learn More

Broad Area Announcement (BAA) by FDA for Extramural Funding Opportunities

BAA Released February 14, 2018 and will remain “open until further notice”

Rivkin Center for Ovarian Cancer

RFP Released September 5, 2017; Application Deadlines vary.

The Rivkin Center out of Seattle, WA offers multiple streams of funding to support ovarian cancer across the country. Please follow the link for current requests for eligibility, (varies with grant type) applications, guidelines, and forms.

The Rivkin Center has added one-year awards at $75,000 each, Pilot Study Program awards will support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered. For additional information: